Answers are grounded in this paper and cite their sources.
Multi-meta-omics reveals metabolic dysregulation in non-celiac gluten sensitivity, suggesting microbiome involvement in its pathophysiology.
Non-celiac gluten sensitivity (NCGS) is an emerging diagnosis with symptoms that overlap with irritable bowel syndrome (IBS). Using shotgun metagenomics and metabolomics, we report deeper insights into the microbiome profile, including viral and archaeal diversity, lower fructan degradation potential, the differential abundance of metabolites, and genomic features of gut bacteria in patients with NCGS. Understanding the microbiome associated with this disorder may shed light on the possible role of the microbiome in the pathophysiology of NCGS.
No takes yet. Share an insight, caveat, or question.
Dixit et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: